Stephen Toon

1.3k total citations
46 papers, 1.1k citations indexed

About

Stephen Toon is a scholar working on Pharmacology, Pharmacology and Molecular Biology. According to data from OpenAlex, Stephen Toon has authored 46 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pharmacology, 13 papers in Pharmacology and 8 papers in Molecular Biology. Recurrent topics in Stephen Toon's work include Pharmacogenetics and Drug Metabolism (17 papers), Analytical Chemistry and Chromatography (7 papers) and Analytical Methods in Pharmaceuticals (6 papers). Stephen Toon is often cited by papers focused on Pharmacogenetics and Drug Metabolism (17 papers), Analytical Chemistry and Chromatography (7 papers) and Analytical Methods in Pharmaceuticals (6 papers). Stephen Toon collaborates with scholars based in United Kingdom, United States and Greece. Stephen Toon's co-authors include Malcolm Rowland, Leon Aarons, William Trager, Robert A. O’Reilly, Lawrence K. Low, Milo Gibaldi, Allen J. Sedman, R Gokal, Larry Heimark and Ioannis Niopas and has published in prestigious journals such as Applied and Environmental Microbiology, The Journal of Physical Chemistry and Gut.

In The Last Decade

Stephen Toon

46 papers receiving 972 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stephen Toon United Kingdom 19 403 227 226 160 149 46 1.1k
James E. Patrick United States 20 325 0.8× 184 0.8× 277 1.2× 193 1.2× 228 1.5× 50 1.4k
Mitchell N. Cayen China 21 349 0.9× 239 1.1× 473 2.1× 125 0.8× 221 1.5× 77 1.6k
H.H.W. Thijssen Netherlands 26 658 1.6× 241 1.1× 301 1.3× 98 0.6× 213 1.4× 97 2.4k
Alan Beresford United Kingdom 12 277 0.7× 217 1.0× 333 1.5× 153 1.0× 110 0.7× 20 1.2k
Douglas S. Greene United States 20 268 0.7× 487 2.1× 236 1.0× 84 0.5× 219 1.5× 66 1.4k
P.A. Soons Netherlands 16 261 0.6× 152 0.7× 140 0.6× 69 0.4× 187 1.3× 27 876
Theodor W. Guentert Switzerland 19 394 1.0× 244 1.1× 264 1.2× 144 0.9× 256 1.7× 40 1.1k
Henning Blume Germany 25 278 0.7× 215 0.9× 338 1.5× 188 1.2× 168 1.1× 89 2.1k
Kurt‐Jürgen Hoffmann Sweden 16 256 0.6× 111 0.5× 187 0.8× 180 1.1× 164 1.1× 31 1.0k
W. Dieterle Switzerland 18 182 0.5× 171 0.8× 170 0.8× 97 0.6× 113 0.8× 50 877

Countries citing papers authored by Stephen Toon

Since Specialization
Citations

This map shows the geographic impact of Stephen Toon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen Toon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen Toon more than expected).

Fields of papers citing papers by Stephen Toon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen Toon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen Toon. The network helps show where Stephen Toon may publish in the future.

Co-authorship network of co-authors of Stephen Toon

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen Toon. A scholar is included among the top collaborators of Stephen Toon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen Toon. Stephen Toon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Combes, Robert D., et al.. (2003). Early microdose drug studies in human volunteers can minimise animal testing: Proceedings of a workshop organised by Volunteers in Research and Testing. European Journal of Pharmaceutical Sciences. 19(1). 1–11. 57 indexed citations
2.
Pace, Silvia, Antonio Longo, Stephen Toon, Paul Rolan, & Allan M. Evans. (2000). Pharmacokinetics of propionyl‐ l‐carnitine in humans: evidence for saturable tubular reabsorption. British Journal of Clinical Pharmacology. 50(5). 441–448. 24 indexed citations
3.
Niopas, Ioannis, Stephen Toon, Leon Aarons, & Malcolm Rowland. (1999). The effect of cimetidine on the steady-state pharmacokinetics and pharmacodynamics of warfarin in humans. European Journal of Clinical Pharmacology. 55(5). 399–404. 19 indexed citations
4.
Davis, John D., et al.. (1996). Atovaquone has no effect on the pharmacokinetics of phenytoin in healthy male volunteers. British Journal of Clinical Pharmacology. 42(2). 246–248. 3 indexed citations
5.
Toon, Stephen. (1996). The relevance of pharmacokinetics in the development of biotechnology products. European Journal of Drug Metabolism and Pharmacokinetics. 21(2). 93–103. 21 indexed citations
6.
Beltrami, Vanya, et al.. (1995). Comprehensive Pharmacokinetics of Urinary Human Follicle Stimulating Hormone in Healthy Female Volunteers. Pharmaceutical Research. 12(6). 844–850. 5 indexed citations
7.
Danjou, Philippe, et al.. (1995). P-2-106 Evaluation of the potential pharmacokinetic interaction of venlafaxine and carbamazepine. European Neuropsychopharmacology. 5(3). 310–311. 9 indexed citations
8.
Dixon, J. S., et al.. (1994). The effect of renal function on the pharmacokinetics of ranitidine. European Journal of Clinical Pharmacology. 46(2). 167–71. 11 indexed citations
9.
Alfonso, Miguel, et al.. (1994). Pigment stoichiometry of the Photosystem II reaction center from higher plants. Biochimica et Biophysica Acta (BBA) - Bioenergetics. 1187(2). 187–190. 6 indexed citations
10.
Toon, Stephen, et al.. (1994). Absence of effect of ranitidine on blood alcohol concentrations when taken morning, midday, or evening with or without food. Clinical Pharmacology & Therapeutics. 55(4). 385–391. 15 indexed citations
11.
Cassidy, James, Bret Berner, Keith K. H. Chan, et al.. (1993). Human Transbuccal Absorption of Diclofenac Sodium from a Prototype Hydrogel Delivery Device. Pharmaceutical Research. 10(1). 126–129. 22 indexed citations
12.
Toon, Stephen. (1993). Relevance of Pharmacokinetic Studies in Volunteers. Clinical Pharmacokinetics. 25(4). 259–262. 3 indexed citations
13.
Toon, Stephen, et al.. (1992). Small bowel/nutrition. Gut. 33(1 Suppl). S10–S13. 1 indexed citations
14.
Niopas, Ioannis, Stephen Toon, & Malcolm Rowland. (1991). Further insight into the stereoselective interaction between warfarin and cimetidine in man.. British Journal of Clinical Pharmacology. 32(4). 508–511. 17 indexed citations
15.
Toon, Stephen, et al.. (1990). Pharmacokinetic and pharmacodynamic interaction between the antidepressant tianeptine and oxazepam at steady-state. Psychopharmacology. 101(2). 226–232. 10 indexed citations
16.
Toon, Stephen, et al.. (1988). The racemic metoprolol H2-antagonist interaction. Clinical Pharmacology & Therapeutics. 43(3). 283–289. 28 indexed citations
17.
Toon, Stephen, et al.. (1987). Comparative effects of ranitidine and cimetidine on the pharmacokinetics and pharmacodynamics of warfarin in man. European Journal of Clinical Pharmacology. 32(2). 165–172. 54 indexed citations
18.
Toon, Stephen, Larry Heimark, William Trager, & Robert A. O’Reilly. (1985). Metabolic Fate of Phenprocoumon in Humans. Journal of Pharmaceutical Sciences. 74(10). 1037–1040. 37 indexed citations
19.
Toon, Stephen, et al.. (1983). Structure-pharmacokinetic relationships among the barbiturates in the rat.. Journal of Pharmacology and Experimental Therapeutics. 225(3). 752–763. 85 indexed citations
20.
Toon, Stephen & Malcolm Rowland. (1979). Quantitative Structure Pharmacokinetic Activity Relationships with Some Tetracyclines. Journal of Pharmacy and Pharmacology. 31(Supplement_1). 43P–43P. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026